A study to evaluate how well single and multiple doses of O3R-5671-PRO are tolerated in healthy adult subjects
O3R-5671-CL-101
Phase 1 other active
Quick answer
A study to evaluate how well single and multiple doses of O3R-5671-PRO are tolerated in healthy adult subjects for Inflammatory bowel diseases and psoriasis. is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Inflammatory bowel diseases and psoriasis.
- Phase
- Phase 1
- Modality
- other
- Status
- active